ArticleOncology letters2025

Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis.

Chen-Chuan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.